GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $18,449,000 | +530.7% | 85,060 | +256.9% | 0.08% | +325.0% |
| Q2 2020 | $2,925,000 | +540.0% | 23,833 | +357.2% | 0.02% | +300.0% |
| Q1 2020 | $457,000 | +47.9% | 5,213 | +76.4% | 0.01% | +150.0% |
| Q4 2019 | $309,000 | -94.5% | 2,955 | -93.9% | 0.00% | -95.5% |
| Q3 2019 | $5,593,000 | +382.6% | 48,627 | +623.7% | 0.04% | +340.0% |
| Q2 2019 | $1,159,000 | -71.0% | 6,719 | -71.7% | 0.01% | -47.4% |
| Q1 2019 | $4,000,000 | +854.7% | 23,732 | +452.2% | 0.02% | +375.0% |
| Q4 2018 | $419,000 | -97.2% | 4,298 | -97.5% | 0.00% | -96.8% |
| Q2 2016 | $14,926,000 | +2555.9% | 170,500 | +2008.3% | 0.12% | +2400.0% |
| Q4 2015 | $562,000 | – | 8,087 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |